MDT-012

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDT-012
Drug Alias NameMDT-012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesRaynaud Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrodose Therapeutx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrodose Therapeutx Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesRaynaud Disease

Other Information

ATC CodeN/A
Related LinksN/A